Histopathologic analysis of suspected amiodarone hepatotoxicity.
暂无分享,去创建一个
Randy M. Perse | K. Ishak | F. Mullick | L. Seeff | H. Zimmerman | J. Lewis | S. Benjamin | R. Ranard | B. Ragsdale | R. Perse | E. Rusnock | A. Wolke | R. M. Perse | J. Lewis
[1] P. K. Lim,et al. Neuropathy and fatal hepatitis in a patient receiving amiodarone. , 1984, British medical journal.
[2] K. Tordjman,et al. Amiodarone and the liver. , 1985, Annals of internal medicine.
[3] V. Huckell,et al. Diffuse alveolar damage syndrome associated with amiodarone therapy. , 1983, Canadian Medical Association journal.
[4] J. Lupón-Rosés,et al. Probable early acute hepatitis with parenteral amiodarone , 1986, Clinical cardiology.
[5] T. Sarna,et al. Clinical and morphologic effects of amiodarone on the liver. , 1985, Gastroenterology.
[6] K. Kenyon,et al. Amiodarone keratopathy: drug-induced lipid storage disease. , 1981, Archives of ophthalmology.
[7] M. Pirovino,et al. Amiodarone‐induced hepatic phospholipidosis: Correlation of morphological and biochemical findings in an animal model , 1988, Hepatology.
[8] J. Porterfield,et al. Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases. , 1987, American journal of clinical pathology.
[9] Gilinsky Nh,et al. Fatal amiodarone hepatoxicity. , 1988 .
[10] P. Yagupsky,et al. Fatal hepatic failure and encephalopathy associated with amiodarone therapy. , 1985, The Journal of pediatrics.
[11] S. Sherlock,et al. Impaired oxidation of debrisoquine in patients with perhexiline liver injury. , 1984, Gut.
[12] H. Goldberg,et al. Increased hepatic density and phospholipidosis due to amiodarone. , 1985, AJR. American journal of roentgenology.
[13] Hamad Jf. Coronary angioplasty in refractory unstable angina. , 1986 .
[14] J. Hoofnagle,et al. Reye's syndrome-like illness in a patient receiving amiodarone. , 1988, The American journal of gastroenterology.
[15] H. Zimmerman,et al. Alcoholic steatonecrosis. I. Relationship between severity of hepatic disease and presence of Mallory bodies in the liver. , 1971, Gastroenterology.
[16] J. Mason. Drug therapy: amiodarone , 1987 .
[17] M. Kew,et al. Liver damage associated with perhexiline maleate. , 1979, Gut.
[18] K. Hostetler,et al. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone. , 1988, Biochimica et biophysica acta.
[19] F. Lacheretz,et al. Recovery from Amiodarone-Induced Lipidosis in Laboratory Animals: A Toxicological Study , 1984 .
[20] L. Horowitz,et al. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. , 1982, The American journal of cardiology.
[21] D. Capron-Chivrac,et al. [Acute hepatopathy caused by amiodarone. Study of a case and review of the literature]. , 1985, Gastroenterologie clinique et biologique.
[22] E. McGuire,et al. Morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol treatment. , 1975, Toxicology and applied pharmacology.
[23] O. Wassermann,et al. NMR-studies on the molecular basis of drug-induced phospholipidosis--II. Interaction between several amphiphilic drugs and phospholipids. , 1976, Biochemical pharmacology.
[24] P. Jap,et al. Amiodarone-induced lysosomal inclusions in primary cultures of human hepatocytes. , 1987, Gastroenterology.
[25] R. Lagacé,et al. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. , 1975, Canadian Medical Association journal.
[26] N. Shepherd,et al. Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study. , 1987, Journal of clinical pathology.
[27] R. Peters,et al. Alcoholic foamy degeneration ― a pattern of acute alcoholic injury of the liver , 1983 .
[28] R. Winkle,et al. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. , 1983, Circulation.
[29] P. Armstrong,et al. Amiodarone hepatotoxicity simulating alcoholic liver disease. , 1984, The New England journal of medicine.
[30] H. Zimmerman,et al. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .
[31] D. Dhumeaux,et al. Amiodarone‐induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease , 1988, Hepatology.
[32] E. Chew,et al. Amiodarone-induced cornea verticillata. , 1982, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[33] S Kacew,et al. Amiodarone-induced phospholipidosis in rat alveolar macrophages. , 1988, The American review of respiratory disease.
[34] Adams Pc,et al. Hepatic effects of amiodarone. , 1986 .
[35] M Bichara,et al. Perhexiline maleate-induced cirrhosis. , 1979, Gastroenterology.
[36] M. Josephson,et al. Amiodarone Hepatotoxicity: A Clinicopathologic Study of Five Patients , 1986 .
[37] J. Rumessen. Hepatotoxicity of amiodarone. , 2009, Acta medica Scandinavica.
[38] M. Dake,et al. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. , 1985, The American journal of medicine.
[39] K. Ishak,et al. Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients , 1989, Hepatology.
[40] J. Bombí,et al. Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease. , 1977, Gastroenterology.
[41] K. Nagashima,et al. DRUG‐INDUCED GENERALIZED PHOSPHOLIPIDOSIS , 1972, Acta pathologica japonica.
[42] E. Downar,et al. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. , 1984, Gastroenterology.
[43] R. Crapo,et al. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. , 1986, The Canadian journal of cardiology.
[44] R. Lüllmann-Rauch,et al. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. , 1975, CRC critical reviews in toxicology.
[45] D. Dhumeaux,et al. Chronic liver disease after low daily doses of amiodarone. Report of three cases. , 1986, Journal of hepatology.